Patent application number | Description | Published |
20130013023 | ELECTRICAL STIMULATION OF THE SYMPATHETIC NERVE CHAIN - The present invention provides a method of affecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. Preferably, the present invention provides a method of affecting a variety of physiological disorders or pathological conditions by placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and stimulating the at least one ganglion until the physiological disorder or pathological condition has been affected. | 01-10-2013 |
20130018436 | ELECTRICAL STIMULATION OF THE SYMPATHETIC NERVE CHAIN - The present invention provides a method of affecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. Preferably, the present invention provides a method of affecting a variety of physiological disorders or pathological conditions by placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and stimulating the at least one ganglion until the physiological disorder or pathological condition has been affected. | 01-17-2013 |
20130123877 | ELECTRICAL STIMULATION OF THE SYMPATHETIC NERVE CHAIN - The present invention provides a method of affecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. Preferably, the present invention provides a method of affecting a variety of physiological disorders or pathological conditions by placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and stimulating the at least one ganglion until the physiological disorder or pathological condition has been affected. | 05-16-2013 |
20130131770 | ELECTRICAL STIMULATION OF THE SYMPATHETIC NERVE CHAIN - The present invention provides a method of affecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. Preferably, the present invention provides a method of affecting a variety of physiological disorders or pathological conditions by placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and stimulating the at least one ganglion until the physiological disorder or pathological condition has been affected. | 05-23-2013 |
20130172953 | METHODS AND SYSTEMS FOR TREATING ACUTE HEART FAILURE BY NEUROMODULATION - Methods of treating acute heart failure in a patient in need thereof. Methods include inserting a therapy delivery device into a pulmonary artery of the patient and applying a therapy signal to autonomic cardiopulmonary fibers surrounding the pulmonary artery. The therapy signal affects heart contractility more than heart rate. Specifically, the application of the therapy signal increases heart contractility and treats the acute heart failure in the patient. The therapy signal can include electrical or chemical modulation. | 07-04-2013 |
20130178829 | METHODS OF TREATING MEDICAL CONDITIONS BY TRANSVASCULAR NEUROMODULATION OF THE AUTONOMIC NERVOUS SYSTEM - The present invention is directed to a method of treating a respiratory or pulmonary condition in a patient by transvascular neuromodulation of an adrenal gland or neural structures that innervate the adrenal gland or components thereof. Methods also include implanting a controller in the patient to control delivery of a therapy signal to the patient's adrenal gland. The therapy signal can be an electrical and/or chemical signal. | 07-11-2013 |
20130274824 | NEUROMODULATORY METHOD FOR TREATING CHRONIC RHINOSINUSITIS - One aspect of the present invention includes a method for treating chronic rhinosinusitis (CRS) in a subject. One step of the method includes implanting a therapy delivery system in the subject so that at least one therapy delivery component of the system is positioned substantially adjacent a target location where modulation of the autonomic nervous system (ANS) is effective to treat CRS. The therapy delivery component includes at least one electrode configured to deliver electric current to the target location. Next, electric current is delivered to the at least one electrode to effect a change in the ANS. | 10-17-2013 |
20130274831 | NEUROMODULATORY METHOD FOR TREATING CHRONIC OR REFRACTORY RHINITIS - One aspect of the present disclosure includes a method for treating chronic or refractory rhinitis in a subject. One step of the method includes implanting a therapy delivery system in the subject so that at least one therapy delivery component of the system is positioned substantially adjacent a target location where modulation of the autonomic nervous system (ANS) is effective to treat chronic or refractory rhinitis. The therapy delivery component includes at least one electrode configured to deliver electric current to the target location. Next, electric current is delivered to the at least one electrode to effect a change in the ANS. | 10-17-2013 |
20130317474 | METHOD OF IMPROVING NEUROPSYCHOLOGICAL FUNCTION IN PATIENTS WITH NEUROCOGNITIVE DISORDERS - The present invention provides methods of improving neuropsychological function in a patient having a neurocognitive disorder by chemical or electrically modulating a target site(s) in the ventral striatum/ventral capsule region. Methods also include modulating the treatment based on a closed-loop feedback system that measures bodily activities associated with the neuropsychological function (i.e. that help to determine whether a neuropsychological function is or can be improved. | 11-28-2013 |
20140052214 | ELECTRICAL STIMULATION OF THE SYMPATHETIC NERVE CHAIN - The present invention provides a method of effecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. Preferably, the present invention provides a method of effecting a variety of physiological disorders or pathological conditions by placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and stimulating the at least one ganglion until the physiological disorder or pathological condition has been effected. | 02-20-2014 |
20140065107 | DEVICES, SYSTEMS, AND METHODS FOR MODULATING UTERINE FUNCTION - One aspect of the present disclosure relates to a method for modulating uterine function in a mammal. One step of the method includes placing a therapy delivery device into direct contact with a spinal cord target associated with uterine function. Next, the therapy delivery device is activated to deliver a therapy signal to the spinal cord target in an amount and for a time sufficient to effect a change in sympathetic and/or parasympathetic activity in the mammal and thereby modulate uterine function. | 03-06-2014 |
20140067021 | DEVICES, SYSTEMS, AND METHODS FOR TREATING CIRCADIAN RHYTHM DISORDERS - One aspect of the present disclosure relates to a method for treating a circadian rhythm disorder in a mammal. One step of the method includes placing a therapy delivery device into electrical communication with an autonomic nervous system (ANS) nerve target associated with the circadian rhythm disorder. Next, the therapy delivery device is activated to deliver a therapy signal to the ANS nerve target in an amount and for a time sufficient to effect a change in sympathetic and/or parasympathetic activity in the mammal and thereby treat the circadian rhythm disorder. | 03-06-2014 |
20140074069 | METHODS AND SYSTEMS FOR TREATING ACUTE HEART FAILURE BY NEUROMODULATION - Methods of treating acute heart failure in a patient in need thereof. Methods include inserting a therapy delivery device into a pulmonary artery of the patient and applying a therapy signal to autonomic cardiopulmonary fibers surrounding the pulmonary artery. The therapy signal affects heart contractility more than heart rate. Specifically, the application of the therapy signal increases heart contractility and treats the acute heart failure in the patient. The therapy signal can include electrical or chemical modulation. | 03-13-2014 |
20140081355 | APPARATUS, SYSTEMS, AND METHODS FOR TREATING BODY ORGAN AGING - One aspect of the present disclosure relates to a method for treating body organ aging in a mammal. One step of the method includes identifying at least one target organ in need of a therapy signal. Next, a therapy delivery device is placed into electrical communication with an autonomic nervous system (ANS) nerve target and/or a central nervous system (CNS) nerve target associated with the at least one target organ. The therapy delivery device is then activated to deliver the therapy signal to the ANS nerve target and/or the CNS nerve target in an amount and for a time sufficient to effect a change in sympathetic and/or parasympathetic activity associated with the at least one target organ. | 03-20-2014 |